1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: MAYO-803201
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 55
Sponsor: NCI
Protocol IDs: DFCI-79049, NCI-T84-0176D, T84-0176
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-AML-87, NCI-T86-0203D, T86-0203
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8862
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8820
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 through 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9405, POG-ALINC-16/SR
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941
|
|
10.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: PD-1003-01, NCI-V94-0598
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000064498, EORTC-06951, FRE-LALA-94, NCT00002700
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI
Protocol IDs: CCG-1952, NCT00002744
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 6 months to under 21
Sponsor: NCI
Protocol IDs: COG-C5961, CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, NCT00002757
|
|
14.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: any age
Sponsor: NCI, Other
Protocol IDs: CDR0000064708, U10CA031946, CLB-9583, CALGB-9583, NCT00002760
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: COG-2961, CCG-2961, NCT00002798
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-1951, NCT00002816
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-8892, CLB-E8892, SWOG-E8892, NCT00002881, E8892
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: SAKK 38/97, SWS-SAKK-38/97, EU-97037, NCT00003215
|
|
20.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 16
Sponsor:
Protocol IDs: MRC-LEUK-AML12CH, EU-98010, NCT00003436
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: COG-A2971, CCG-A2971, POG-A2971, CCG-29701, A2971, NCT00003593
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 15
Sponsor: NCI
Protocol IDs: POG-7220/21
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: POG-7420/21, MDAR-23, POG-ALINC-11
|
Mobile | Español
